Top

Published in:

01-08-2003 | Neonatal and Pediatric Intensive Care

Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury

Authors: Antonio Chiaretti, Marco Piastra, Giancarlo Polidori, Concezio Di Rocco, Elena Caresta, Alessia Antonelli, Tiziana Amendola, Luigi Aloe

Published in: Intensive Care Medicine | Issue 8/2003

Abstract

Objectives

We evaluated the neurotrophic factors [nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glia-derived neurotrophic factor (GDNF)] expression and their association with the severity and outcome of children with traumatic brain injury.

Design

Prospective observational clinical study.

Setting

Pediatric intensive care unit.

Patients

Fourteen children with severe head injury; 12 controls with obstructive hydrocephalus.

Measurement

Cerebrospinal fluid (CSF) and plasma samples were collected 2 h (T1) and 24 h (T2) after head injury. Neurotrophic factor levels were measured using an immuno-enzymatic assay.

Main results

In patients, neurotrophic factor mean levels were significantly different in both CSF and plasma, showing high levels of BDNF compared to NGF and GDNF. Considering T1 and T2 expression, in the CSF the level of NGF increased from 3.5±0.4 pg/ml to 48.2±11.7 pg/ml (p<0.001); BDNF decreased from 4854.0±1303.7 pg/ml to 593.0±114.8 pg/ml (p<0.001), while GDNF did not undergo significant variations. In plasma, no significant changes were observed. Regarding severity and outcome, BDNF levels showed a sharp peak after head injury, but the only significant association was between NGF expression in the CSF and a good outcome versus a poor outcome (p=0.007).

Conclusions

The variations in neurotrophic factor levels reflect an endogenous attempt at neuroprotection against biochemical and molecular changes after traumatic head injury. BDNF represents an early marker of brain injury, while NGF expression in the CSF was indicative of a good outcome and the role of this neurotrophin in the treatment of children with severe head injury may be hypothesized.

Sharples PM, Storey A, Aynsley-Green A, Eyre JA (1990) Avoidable factors contributing to death of children with head injury. BMJ 300:87–91PubMed

Kim DH, Gutin PH, Noble LJ, Nathan D, Yu JS, Nockels RP (1996) Treatment with genetically engineered fibroblast producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat. Neuroreport 7:2221–2225PubMed

Barde YA (1989) Trophic factors and neuronal survival. Neuron 2:1525–1534PubMed

Sinson G, Perri BR, Trojanowsky JQ, Flamm ES, McIntosh TK (1997) Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental brain injury. J Neurosurg 86:511–518PubMed

Barde YA (1994) Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res 390:1855–1859

Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237:1154–1161PubMed

Lewin G, Barde YA (1996) Physiology of the neurotrophins. Ann Rev Neurosci 19:289–317

Cheng B, Mattson MP (1994) NT-3 and BDNF protect neurons against metabolic/excitotoxic insult. Brain Res 640:56–67CrossRefPubMed

Baloh RH, Enomoto H, Johnson EM Jr, Milbrandt J (2000) The GDNF family ligands and receptors—implications for neural development. Curr Opin Neurobiol 10:103–110PubMed

10.

Sofroniew MV, Howe CL, Mobley W (2001) Nerve growth factor signalling, neuroprotection and neural repair. Ann Rev Neurosci 24:1217–1281CrossRefPubMed

11.

Lee TH, Kato H, Chen ST, Kogure K, Itoyama Y (1998) Expression of nerve growth factor after transient focal cerebral ischemia in rats. Stroke 29:1687–1697PubMed

12.

Hashimoto Y, Kawatsura H, Shiga Y, Furukawa S, Shigeno T (1992) Significance of nerve growth factor levels after transient forebrain ischemia in gerbils. Neurosci Lett 139:45–46CrossRefPubMed

13.

Abe K (2000) Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 20:1393–1408PubMed

14.

Ikeda T, Xia XY, Xia YX, Ikenoue T, Han B, Choi BH (2000) Glial cell line-derived neurotrophic factor protects against ischemia-hypoxia-induced brain injury in neonatal rat. Acta Neuropathol (Berl) 100:161–167

15.

Mocchetti I, Wrathall JR (1995) Neurotrophic factors in central nervous system trauma. J Neurotrauma 12:853–870PubMed

16.

Kromer LF (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214–216PubMed

17.

Holtzman DM, Sheldon RA, Jaffe W, Cheng Y, Ferriero D (1996) Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 39:114–122PubMed

18.

Dixon CE, Flinn P, Bao J, Venya R, Hayes RL (1997) Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp Neurol 146:479–490CrossRefPubMed

19.

Kim BT, Rao VL, Sailor KA, Bowen KK, Dempsey RJ (2001) Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats. J Neurosurg 95:674–679PubMed

20.

Cheng B, Mattson MP (1991) NGF and BDNF protect rat hippocampal and human cortical neurons against hypoglicemic damage by stabilizing calcium homeostasis. Neuron 7:1031–1041PubMed

21.

Almli CR, Levy TJ, Han BH, Shah AR, Gidday JM, Holtzman DM (2000) BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp Neurol 166:99–114CrossRefPubMed

22.

Connor B, Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 27:1–39CrossRefPubMed

23.

Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Rev 33:199–227CrossRefPubMed

24.

Lappalainen R, Lindholm D, Riikonen R (1996) Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 11:296–300PubMed

25.

Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Philips TM (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49:597–606

26.

Kim JI, Roh JK, Lee SK, Chung CK (2002) Neurotrophin receptor immunoreactivity in severe cerebral cortical dysplasia. Epilepsia 43 (Suppl 5):220–226CrossRefPubMed

27.

Azmitia EC (2001) Neuronal instability: implications for Rett's syndrome. Brain Dev 23 (Suppl 1): S1-S10CrossRef

28.

Aronica E, Leenstra S, Jansen GH, van Veelen CW, Yankaya B, Troost D (2001) Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with epilepsy: colocalization with N-methyl-D acid receptor. Acta Neuropathol 101:383–392PubMed

29.

Korhonen L, Riikonen R, Nawa H, Lindholm D (1998) Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia. Neurosci Lett 240:151–154CrossRefPubMed

30.

Kanai M, Numakura C, Sasaki A, Shirahata E, Akaba K, Hashimoto M, Hasegawa H, Shirasawa S, Hayasaka K (2002) Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case. Tohoku J Exp Med 196:241–246PubMed

31.

Lui VC, Samy ET, Sham MH, Mulligan LM, Tam PK (2002) Glial cell line-derived neurotrophic factor family receptors are abnormally expressed in aganglionic bowel of a subpopulation of patients with Hirschsprung's disease. Lab Invest 82:703–712PubMed

32.

Seguier-Lipszyc E, El-Ghoneimi A, Brinon C, Florentin A, Simonneau M Aigrain Y, Peuchmaur M (2001) GDNF expression in Wilms tumor. J Urol 165:2269–2273PubMed

33.

Tokunaga Y, Kira R, Takahata Y, Gondo K, Mizuno Y, Aoki T, Hara T (2002) Neurotrophin-4 and glial cell line-derived neurotrophic factor in cerebral fluid from meningitis/encephalitis patients. Pediatr Neurol 27:102–105CrossRefPubMed

34.

Nieto-Sampiedro M, Lewis ER, Cotman CW, Manthorpe M, Skaper SD, Barbin G, Longo FM, Varon S (1982) Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science 217:860–861PubMed

35.

Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambajashi J, Sun B, Tandon NN (2002) Brain derived neurotrophic factor is stored in human platelets and release by agonist stimulation. Thromb Haemost 87:728–734PubMed

36.

Nakahashi T, Fujimura H, Altar CA, Li J, Kambajashi J, Tandon NN, Sun B (2000) Vascular endothelial cells synthesize and secrete brain derived neurotrophic factor. FEBS Lett 470:113–117CrossRefPubMed

37.

Longo FM, Selak I, Zovickian J, Manthorpe M, Varon S, U HS (1984) Neuronotrophic activities in cerebrospinal fluid of head trauma patients. Exp Neurol 84:207–218PubMed

38.

DeKosky ST, Goss JR, Miller PD, Styren SD, Kochanek PM, Marion D (1994) Upregulation of nerve growth factor following cortical trauma. Exp Neurol 130:173–177CrossRefPubMed

39.

Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC (1997) Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 17:280–289PubMed

40.

Clark RS, Schiding JK, Kaczorowosky SL, Marion DV, Kochaneck PM (1994) Neutrophil accumulation after traumatic brain injury in rat: comparison of weight drop and controlled cortical impact models. J Neurotrauma 11:499–506PubMed

41.

Sherwood ER, Prough DS (2000) Neuroinflammation and secondary brain injury. Crit Care Med 28:1221–1222PubMed

42.

Oyesiku NM, Evans CO, Houston S, Darrell RS, Smith JS, Fulop ZL, Dickson CE, Stein DG (1999) Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain. Brain Res 833:161–172CrossRefPubMed

43.

Patterson SL, Grady MS, Bothwell M (1993) Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 605:43–49CrossRefPubMed

44.

Kossmann T, Hans V, Imhof HG, Trentz O (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 713:143–152PubMed

45.

Murdoch I, Perry EK, Court JA, Graham DI, Dewar D (1998) Cortical cholinergic dysfunction after human head injury. J Neurotrauma 15:295–305PubMed

46.

Dewar D, Graham DI (1996) Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human postmortem study. J Neurotrauma 13:181–187PubMed

47.

Jönhangen ME, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger A, Shigeta M, Theodorsonn E, Viitanen M, Winblad B, Wahlund LO (1998) Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9:246–257PubMed

48.

Seiger A, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A, Lundqvist H, Langstrom B, Meyerson B, Personn A, Viitanen M, Winblad B, Olson L (1993) Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res 57:255–261CrossRefPubMed

49.

Olson L, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A, Wahlund LO (1992) Nerve growth factor affects¹¹C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm 4:79–95

50.

Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155–2162PubMed

51.

Fisher A, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65–68

52.

Lauterborn JC, Tran TM, Isackson PJ, Gall CM (1993) Nerve growth factor mRNA is expressed by GABAergic neurons in rat hippocampus. Neuroreport 5:273–276PubMed

53.

Grundy PL, Patel N, Harbuz MS, Lightman SL, Sharples PM (2001) Glucocorticoids modulate the NGF mRNA response in the rat hippocampus after traumatic brain injury. Brain Res 892:386–390CrossRefPubMed

54.

Alderson P, Roberts I (1997) Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trial. BMJ 314:1855–1859PubMed

Title: Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury
Authors: Antonio Chiaretti
Marco Piastra
Giancarlo Polidori
Concezio Di Rocco
Elena Caresta
Alessia Antonelli
Tiziana Amendola
Luigi Aloe
Publication date: 01-08-2003
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 8/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-1852-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury

Abstract

Objectives

Design

Setting

Patients

Measurement

Main results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Design

Setting

Patients

Measurement

Main results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2003

Relationship between injury severity and lactate levels in severely injured patients

Alveolar recruitment of atelectasis under combined high-frequency jet ventilation: a computed tomography study

Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?

Tubular proteinuria and enzymuria following open heart surgery

Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock

The introduction of positive endexpiratory pressure into mechanical ventilation: a retrospective